{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:11:40Z","timestamp":1740107500783,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T00:00:00Z","timestamp":1626480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T00:00:00Z","timestamp":1626480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005671","name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa e \u00e0 Inova\u00e7\u00e3o Tecnol\u00f3gica do Estado de Sergipe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005671","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00436-021-07231-7","type":"journal-article","created":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T06:03:26Z","timestamp":1626501806000},"page":"2959-2964","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antimony resistance associated with persistence of Leishmania (Leishmania) infantum infection in macrophages"],"prefix":"10.1007","volume":"120","author":[{"given":"Lucas Sousa","family":"Magalh\u00e3es","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lays Gisele Santos","family":"Bomfim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla Nat\u00e1lia Oliveira","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscila Lima","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego Moura","family":"Tanajura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Wheeler","family":"Lipscomb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Am\u00e9lia Ribeiro","family":"de Jesus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roque Pacheco","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana Rodrigues","family":"de Moura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,17]]},"reference":[{"key":"7231_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1099\/jmm.0.46841-0","volume":"56","author":"Ashutosh","year":"2007","unstructured":"Ashutosh, Sundar S, Goyal N (2007) Molecular mechanisms of antimony resistance in Leishmania. J Med Microbiol 56:143\u2013153. https:\/\/doi.org\/10.1099\/jmm.0.46841-0","journal-title":"J Med Microbiol"},{"key":"7231_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF01973598","volume":"13","author":"R Badar\u00f3","year":"1994","unstructured":"Badar\u00f3 R, Nascimento C, Carvalho JS et al (1994) Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral leishmaniasis. Eur J Clin Microbiol Infect Dis 13:23\u201328. https:\/\/doi.org\/10.1007\/BF01973598","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"7231_CR3","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","volume":"392","author":"S Burza","year":"2018","unstructured":"Burza S, Croft SL, Boelaert M (2018) Leishmaniasis Lancet 392:951\u2013970. https:\/\/doi.org\/10.1016\/S0140-6736(18)31204-2","journal-title":"Leishmaniasis Lancet"},{"key":"7231_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2019.00330","volume":"9","author":"F Concei\u00e7\u00e3o-Silva","year":"2019","unstructured":"Concei\u00e7\u00e3o-Silva F, Morgado FN (2019) Leishmania spp-host interaction: there is always an onset, but is there an end? Front Cell Infect Microbiol 9:1\u201314. https:\/\/doi.org\/10.3389\/fcimb.2019.00330","journal-title":"Front Cell Infect Microbiol"},{"key":"7231_CR5","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1042\/BST0391268","volume":"39","author":"L Coppo","year":"2011","unstructured":"Coppo L, Ghezzi P (2011) Thiol regulation of pro-inflammatory cytokines and innate immunity: protein S-thiolation as a novel molecular mechanism. Biochem Soc Trans 39:1268\u20131272. https:\/\/doi.org\/10.1042\/BST0391268","journal-title":"Biochem Soc Trans"},{"key":"7231_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00436-013-3621-y","volume":"113","author":"AF De Azevedo","year":"2014","unstructured":"De Azevedo AF, De Lisboa Dutra JL, Barbosa Santos ML et al (2014) Fatty acid profiles in Leishmania spp. isolates with natural resistance to nitric oxide and trivalent antimony. Parasitol Res 113:19\u201327. https:\/\/doi.org\/10.1007\/s00436-013-3621-y","journal-title":"Parasitol Res"},{"key":"7231_CR7","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00436-015-4793-4","volume":"115","author":"TR de Moura","year":"2016","unstructured":"de Moura TR, Santos MLB, Braz JM et al (2016) Cross-resistance of Leishmania infantum isolates to nitric oxide from patients refractory to antimony treatment, and greater tolerance to antileishmanial responses by macrophages. Parasitol Res 115:713\u2013721. https:\/\/doi.org\/10.1007\/s00436-015-4793-4","journal-title":"Parasitol Res"},{"key":"7231_CR8","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.3390\/molecules14072317","volume":"14","author":"F Fr\u00e9zard","year":"2009","unstructured":"Fr\u00e9zard F, Demicheli C, Ribeiro RR (2009) Pentavalent antimonials: new perspectives for old drugs. Molecules 14:2317\u20132336. https:\/\/doi.org\/10.3390\/molecules14072317","journal-title":"Molecules"},{"key":"7231_CR9","doi-asserted-by":"publisher","unstructured":"Giudice A, Vendrame C, Bezerra C et al (2012) Macrophages participate in host protection and the disease pathology associated with Leishmania braziliensis infection. BMC Infect Dis 12. https:\/\/doi.org\/10.1186\/1471-2334-12-75","DOI":"10.1186\/1471-2334-12-75"},{"key":"7231_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1034\/j.1399-3003.1999.14a17.x","volume":"14","author":"P Gosset","year":"1999","unstructured":"Gosset P, Wallaert B, Tonnel AB, Fourneau C (1999) Thiol regulation of the production of TNF-\u03b1, IL-6 and IL-8 by human alveolar macrophages. Eur Respir J 14:98\u2013105. https:\/\/doi.org\/10.1034\/j.1399-3003.1999.14a17.x","journal-title":"Eur Respir J"},{"key":"7231_CR11","doi-asserted-by":"publisher","first-page":"13704","DOI":"10.1016\/S0021-9258(18)33504-X","volume":"257","author":"OW Griffith","year":"1982","unstructured":"Griffith OW (1982) Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis. J Biol Chem 257:13704\u201313712","journal-title":"J Biol Chem"},{"key":"7231_CR12","first-page":"996","volume":"296","author":"JJE Haddad","year":"2001","unstructured":"Haddad JJE, Safieh-Garabedian B, Saad\u00e9 NE, Land SC (2001) Thiol regulation of pro-inflammatory cytokines reveals a novel immunopharmacological potential of glutathione in the alveolar epithelium. J Pharmacol Exp Ther 296:996\u20131005","journal-title":"J Pharmacol Exp Ther"},{"key":"7231_CR13","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1007\/s00436-019-06443-2","volume":"118","author":"S Hendrickx","year":"2019","unstructured":"Hendrickx S, Caljon G, Maes L (2019) Need for sustainable approaches in antileishmanial drug discovery. Parasitol Res 118:2743\u20132752. https:\/\/doi.org\/10.1007\/s00436-019-06443-2","journal-title":"Parasitol Res"},{"key":"7231_CR14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1550-7408.2012.00636.x","volume":"59","author":"M Jirk\u016f","year":"2012","unstructured":"Jirk\u016f M, Yurchenko VY, Luke\u0161 J, Maslov DA (2012) New species of insect trypanosomatids from costa rica and the proposal for a new subfamily within the Trypanosomatidae. J Eukaryot Microbiol 59:537\u2013547. https:\/\/doi.org\/10.1111\/j.1550-7408.2012.00636.x","journal-title":"J Eukaryot Microbiol"},{"key":"7231_CR15","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1046\/j.1365-3156.2000.00565.x","volume":"5","author":"P Kapoor","year":"2000","unstructured":"Kapoor P, Sachdev M, Madhubala R (2000) Inhibition of glutathione synthesis as a chemotherapeutic strategy for leishmaniasis. Trop Med Int Health 5:438\u2013442. https:\/\/doi.org\/10.1046\/j.1365-3156.2000.00565.x","journal-title":"Trop Med Int Health"},{"key":"7231_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1371\/journal.pone.0014394","volume":"5","author":"R Khouri","year":"2010","unstructured":"Khouri R, Novais F, Santana G et al (2010) DETC induces Leishmania parasite killing in human in vitro and murine in vivo models: a promising therapeutic alternative in Leishmaniasis. PLoS One 5:9. https:\/\/doi.org\/10.1371\/journal.pone.0014394","journal-title":"PLoS One"},{"key":"7231_CR17","first-page":"570","volume":"69","author":"FY Liew","year":"1990","unstructured":"Liew FY, Parkinson C, Millott S et al (1990) Tumour necrosis factor (TNF\u03b1) in leishmaniasis. I. TNF\u03b1 mediates host protection against cutaneous leishmaniasis. Immunology 69:570\u2013573","journal-title":"Immunology"},{"key":"7231_CR18","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nm.3221","volume":"19","author":"DS Lima-Junior","year":"2013","unstructured":"Lima-Junior DS, Costa DL, Carregaro V et al (2013) Inflammasome-derived IL-1\u03b2 production induces nitric oxide-mediated resistance to Leishmania. Nat Med 19:909\u2013915. https:\/\/doi.org\/10.1038\/nm.3221","journal-title":"Nat Med"},{"key":"7231_CR19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2174\/156802606776743165","volume":"6","author":"PM Loiseau","year":"2006","unstructured":"Loiseau PM, Bories C (2006) Mechanisms of drug action and drug resistance in Leishmania as basis for therapeutic target identification and design of antileishmanial modulators. Curr Top Med Chem 6:539\u2013550. https:\/\/doi.org\/10.2174\/156802606776743165","journal-title":"Curr Top Med Chem"},{"key":"7231_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1590\/0074-02760170289","volume":"113","author":"LS Magalh\u00e3es","year":"2018","unstructured":"Magalh\u00e3es LS, Bomfim LG, Mota SG et al (2018) Increased thiol levels in antimony-resistant Leishmania infantum isolated from treatment-refractory visceral leishmaniasis in Brazil. Mem Inst Oswaldo Cruz 113:119\u2013125. https:\/\/doi.org\/10.1590\/0074-02760170289","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"7231_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1006\/cyto.2002.1014","volume":"17","author":"D Mazzeo","year":"2002","unstructured":"Mazzeo D, Sacco S, Di Lucia P et al (2002) Thiol antioxidants inhibit the formation of the interleukin-12 heterodimer: a novel mechanism for the inhibition of IL-12 production. Cytokine 17:285\u2013293. https:\/\/doi.org\/10.1006\/cyto.2002.1014","journal-title":"Cytokine"},{"key":"7231_CR22","doi-asserted-by":"publisher","first-page":"E575","DOI":"10.1073\/pnas.1213839110","volume":"110","author":"B Mukherjee","year":"2013","unstructured":"Mukherjee B, Mukhopadhyay R, Bannerjee B et al (2013) Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1. Proc Natl Acad Sci U S A 110:E575\u2013E582. https:\/\/doi.org\/10.1073\/pnas.1213839110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7231_CR23","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.1402585","volume":"195","author":"B Mukherjee","year":"2015","unstructured":"Mukherjee B, Paul J, Mukherjee S et al (2015) Antimony-resistant Leishmania donovani exploits miR-466i to deactivate host MyD88 for regulating IL-10\/IL-12 levels during early hours of infection. J Immunol 195:2731\u20132742. https:\/\/doi.org\/10.4049\/jimmunol.1402585","journal-title":"J Immunol"},{"key":"7231_CR24","doi-asserted-by":"publisher","first-page":"10383","DOI":"10.1073\/pnas.93.19.10383","volume":"93","author":"R Mukhopadhyay","year":"1996","unstructured":"Mukhopadhyay R, Dey S, Xut N et al (1996) Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania. Proc Natl Acad Sci USA 93:10383\u201310387. https:\/\/doi.org\/10.1073\/pnas.93.19.10383","journal-title":"Proc Natl Acad Sci USA"},{"key":"7231_CR25","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1172\/JCI117767","volume":"95","author":"HW Murray","year":"1995","unstructured":"Murray HW, Cervia JS, Hariprashad J et al (1995) Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis. J Clin Invest 95:1183\u20131192. https:\/\/doi.org\/10.1172\/JCI117767","journal-title":"J Clin Invest"},{"key":"7231_CR26","doi-asserted-by":"publisher","unstructured":"Pessenda G, Santana da Silva J (2020) Arginase and its mechanisms in Leishmania persistence. Parasite Immunol e12722. https:\/\/doi.org\/10.1111\/pim.12722","DOI":"10.1111\/pim.12722"},{"key":"7231_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006052","volume":"11","author":"A Ponte-Sucre","year":"2017","unstructured":"Ponte-Sucre A, Gamarro F, Dujardin J et al (2017) Drug resistance and treatment failure in leishmaniasis: a 21st century challenge. PLoS Negl Trop Dis 11:e0006052. https:\/\/doi.org\/10.1371\/journal.pntd.0006052","journal-title":"PLoS Negl Trop Dis"},{"key":"7231_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1590\/S0100-879X1998000100020","volume":"31","author":"A Ribeiro-de-Jesus","year":"1998","unstructured":"Ribeiro-de-Jesus A, Almeida RP, Lessa H et al (1998) Cytokine profile and pathology in human leishmaniasis. Brazilian J Med Biol Res 31:143\u2013148. https:\/\/doi.org\/10.1590\/S0100-879X1998000100020","journal-title":"Brazilian J Med Biol Res"},{"key":"7231_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/intimm\/dxx075","volume":"30","author":"M Rossi","year":"2018","unstructured":"Rossi M, Fasel N (2018) How to master the host immune system? Leishmania parasites have the solutions! Int Immunol 30:103\u2013111. https:\/\/doi.org\/10.1093\/intimm\/dxx075","journal-title":"Int Immunol"},{"key":"7231_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.niox.2012.04.004","volume":"27","author":"PL Santos","year":"2012","unstructured":"Santos PL, Costa RV, Braz JM et al (2012) Leishmania chagasi naturally resistant to nitric oxide isolated from humans and dogs with visceral leishmaniasis in Brazil. Nitric Oxide 27:67\u201371. https:\/\/doi.org\/10.1016\/j.niox.2012.04.004","journal-title":"Nitric Oxide"},{"key":"7231_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0006969","volume":"12","author":"L Turcano","year":"2018","unstructured":"Turcano L, Torrente E, Missineo A et al (2018) Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening. PLoS Negl Trop Dis 12:1\u201321. https:\/\/doi.org\/10.1371\/journal.pntd.0006969","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-021-07231-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-021-07231-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-021-07231-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T15:18:12Z","timestamp":1629213492000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-021-07231-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,17]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["7231"],"URL":"https:\/\/doi.org\/10.1007\/s00436-021-07231-7","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"type":"print","value":"0932-0113"},{"type":"electronic","value":"1432-1955"}],"subject":[],"published":{"date-parts":[[2021,7,17]]},"assertion":[{"value":"29 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the local Research Ethical Committee in the Federal University of Sergipe (advice number 1.353.887). Consent was obtained from each patient or healthy donor.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to submission of and publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that there is no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}